Latest Impairment Charges News

Page 1 of 27
Disney finished fiscal 2026 with strong revenue, adjusted earnings and cash-flow growth, while signalling another year of expansion despite the loss of an extra reporting week. The company is also reshaping its segment reporting to put consumer products closer to its entertainment franchises.
Victor Sage
Victor Sage
17 Nov 2026
Commonwealth Bank of Australia (ASX:CBA) delivered approximately A$2.8 billion in unaudited cash NPAT for 1Q27, with lending and deposit growth lifting income despite higher impairments and arrears. Capital and liquidity remained well above regulatory minimums, but rising risk-weighted assets and non-performing exposures add a note of caution.
Victor Sage
Victor Sage
11 Nov 2026
Myer Holdings crossed the $4 billion sales mark in FY26, but a tougher consumer environment, weaker underlying earnings and $279.6 million of post-tax impairments pushed the department store operator to a $276.5 million statutory loss. The group enters FY27 with $100.1 million of net cash, no final dividend and a large execution burden.
Logan Eniac
Logan Eniac
9 Nov 2026
Australia and New Zealand Banking Group Limited (ASX:AN3) reported a 27% increase in 2026 cash profit to $7.542 billion, helped by substantial cost reductions and stronger fee and trading income. The annual report also flags rising credit impairment, a softer housing market and unfinished regulatory remediation work.
Victor Sage
Victor Sage
9 Nov 2026
ANZ Group Holdings reported a 31% rise in FY26 cash profit to A$7.591 billion, helped by sharp cost reductions and stronger Australian banking performance. The 83-cent final dividend was maintained, but rising impairments, weaker New Zealand earnings and heavier capital demands leave the next phase of the turnaround less straightforward.
Victor Sage
Victor Sage
9 Nov 2026
Franklin Templeton delivered sharply higher fiscal 2026 earnings, supported by $84.1 billion in long-term net inflows and an 8% increase in assets under management. The result also showed a sizeable gap between GAAP and adjusted profit, leaving the quality and durability of the improvement as the key investor question.
Claire Turing
Claire Turing
7 Nov 2026
Regency Centers lifted its 2026 outlook and increased its quarterly common dividend by 6% after stronger third-quarter operating results. The upbeat performance came alongside a sharp decline in GAAP net income, driven partly by a US$65.1 million real estate impairment charge.
Eva Park
Eva Park
6 Nov 2026
Monster Beverage delivered a strong third quarter, with sales rising 16.7% to US$2.56 billion and international revenue climbing 28.1%. The trade-off was narrower margins as aluminium, freight, fuel, marketing and transformation costs increased.
Victor Sage
Victor Sage
6 Nov 2026
Macquarie Bank’s half-year profit fell 61% to A$1.42 billion after a prior-period A$2.448 billion asset-transfer gain dropped out of the comparison. Its core banking and markets divisions still grew, but credit charges rose and margins remained under pressure.
Victor Sage
Victor Sage
6 Nov 2026
Zoetis lifted its full-year adjusted earnings outlook after a mixed third quarter, but US companion animal revenue fell 8% amid price sensitivity, competition and generic pressure. The animal health group also reported an 18% drop in GAAP net income and a US$89 million impairment charge.
Ada Torres
Ada Torres
5 Nov 2026
Rockwell Automation closed fiscal 2026 with stronger sales, margins, earnings and cash flow, while its software business delivered the fastest growth across the group. The industrial automation company expects further organic growth in fiscal 2027, but its latest numbers also benefited from tariff refunds and an easier comparison with last year’s impairment charges.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026

Browse the archive

Full archive